Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05727163
Status:
RECRUITING
Last Update Posted:
2024-03-04
First Post:
2022-10-24
Brief Title:
FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
Sponsor:
Sun Yat-sen University
Organization:
Sun Yat-sen University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-29
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-24
First Submit QC Date:
February 3 2023
Study First Post Date:
2023-02-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-01
Last Update Post Date:
2024-03-04
Last Update Post Date Type:
ACTUAL